BNT162b2 COVID-19 Vaccine has no Adverse Effect on Women’s In Vitro Fertilization Outcomes and Fertility

Purpose: To investigate the effect of BNT162b2 COVID-19 vaccine on women’s fertility. Methods: We prospectively collected data women patients undergoing In Vitro Fertilization (IVF) treatment after completion 2 doses vaccination between February and April 2021 (POST vaccine). For comparison, we reviewed records same before (PRE vaccine) up to 2019. Each woman served as self-control vaccination. Study outcomes were compared PRE- POSTvaccination groups. Clinical pregnancy values assessed if available for both cycles. Results: 47 eligible, with a mean interval 362 ± 368 days two ovum pick-ups. The numbers oocytes retrieved, matured oocytes, fertilization rates, qualities embryos at day 3 before-and-after vaccinations similar all parameters. percentages clinical pregnancies did not differ significantly Conclusion: From our findings, does affect in vitro and, therefore, This study repudiates misinformation from unreliable sources, reassuring improve compliance promote eradication.